- Home
- YYGH vs ICCM Comparison
YYGH vs ICCM Comparison
Compare YYGH & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YYGH
- ICCM
- Stock Information
- Founded
- YYGH 2010
- ICCM 2006
- Country
- YYGH Singapore
- ICCM Israel
- Employees
- YYGH N/A
- ICCM N/A
- Industry
- YYGH
- ICCM
- Sector
- YYGH
- ICCM
- Exchange
- YYGH NYSE
- ICCM Nasdaq
- Market Cap
- YYGH 69.2M
- ICCM 74.7M
- IPO Year
- YYGH 2024
- ICCM N/A
- Fundamental
- Price
- YYGH $1.69
- ICCM $1.21
- Analyst Decision
- YYGH
- ICCM Strong Buy
- Analyst Count
- YYGH 0
- ICCM 1
- Target Price
- YYGH N/A
- ICCM $2.50
- AVG Volume (30 Days)
- YYGH 28.8K
- ICCM 317.5K
- Earning Date
- YYGH 04-01-2025
- ICCM 03-27-2025
- Dividend Yield
- YYGH N/A
- ICCM N/A
- EPS Growth
- YYGH 527.44
- ICCM N/A
- EPS
- YYGH 0.04
- ICCM N/A
- Revenue
- YYGH $37,372,731.00
- ICCM $3,671,000.00
- Revenue This Year
- YYGH N/A
- ICCM $10.03
- Revenue Next Year
- YYGH N/A
- ICCM $62.68
- P/E Ratio
- YYGH $41.04
- ICCM N/A
- Revenue Growth
- YYGH 55.18
- ICCM 26.02
- 52 Week Low
- YYGH $0.72
- ICCM $0.48
- 52 Week High
- YYGH $4.70
- ICCM $1.66
- Technical
- Relative Strength Index (RSI)
- YYGH N/A
- ICCM 43.30
- Support Level
- YYGH N/A
- ICCM $1.15
- Resistance Level
- YYGH N/A
- ICCM $1.34
- Average True Range (ATR)
- YYGH 0.00
- ICCM 0.08
- MACD
- YYGH 0.00
- ICCM -0.02
- Stochastic Oscillator
- YYGH 0.00
- ICCM 28.95
About YYGH YY GROUP HOLDING LIMITED
YY Group Holding Ltd is a data and technology driven company focused on developing enterprise intelligent labor matching services and smart cleaning services founded in Singapore. It provides enterprise manpower outsourcing and smart cleaning services in Singapore and Malaysia. The group has two operating segment, which is cleaning services segment and manpower outsourcing services, Maximum revenue is generated from cleaning services.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.